Loading...
XJPX
2267
Market cap6.18bUSD
Apr 11, Last price  
2,922.50JPY
1D
-0.22%
1Q
1.58%
Jan 2017
-46.08%
Name

Yakult Honsha Co Ltd

Chart & Performance

D1W1MN
P/E
17.37
P/S
1.76
EPS
168.22
Div Yield, %
2.05%
Shrs. gr., 5y
-0.67%
Rev. gr., 5y
4.33%
Revenues
503.08b
+4.14%
247,506,000,000267,707,000,000273,099,000,000317,335,000,000293,490,000,000290,678,000,000305,944,000,000312,552,000,000319,193,000,000350,322,000,000367,980,000,000390,412,000,000378,307,000,000401,569,000,000407,017,000,000406,004,000,000385,706,000,000415,116,000,000483,071,000,000503,079,000,000
Net income
51.01b
+0.72%
14,104,000,00014,442,000,00014,805,000,00016,675,000,00011,324,000,00013,248,000,00013,168,000,00013,291,000,00016,379,000,00022,543,000,00025,056,000,00028,843,000,00030,154,000,00034,064,000,00034,935,000,00039,735,000,00039,267,000,00044,917,000,00050,641,000,00051,006,000,000
CFO
70.70b
-18.28%
19,348,000,00026,919,000,00025,724,000,00025,177,000,00037,559,000,00039,535,000,00040,987,000,00033,444,000,00042,887,000,00048,579,000,00055,407,000,00062,149,000,00059,998,000,00061,989,000,00062,125,000,00062,791,000,00055,820,000,00073,390,000,00086,513,000,00070,702,000,000
Dividend
Mar 28, 20250 JPY/sh
Earnings
May 12, 2025

Profile

Yakult Honsha Co.,Ltd. manufactures and sells food and beverage products, cosmetics, pharmaceuticals, and others. It operates through Food and Beverages (Japan), Food and Beverages (The Americas), Food and Beverages (Asia and Oceania), Food and Beverages (Europe), Pharmaceuticals, and Others segments. The company offers fermented milk drinks, juices, noodles, etc. through its home delivery and retail store channels. It also provides pharmaceutical products, such as Elplat, an antineoplastic drug, as well as generic anti-cancer agents, including Gemcitabine Yakult, Capecitabine, and Gefitinib Yakult tablets. In addition, the company offers cosmetics; and operates the Tokyo Yakult Swallows, a professional baseball team. Yakult Honsha Co.,Ltd. was founded in 1935 and is headquartered in Tokyo, Japan.
URL
https://www.yakult.co.jp/
IPO date
Jan 23, 1980
Employees
29,880
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑03
Income
Revenues
503,079,000
4.14%
483,071,000
16.37%
Cost of revenue
435,055,000
426,383,000
Unusual Expense (Income)
NOPBT
68,024,000
56,688,000
NOPBT Margin
13.52%
11.73%
Operating Taxes
22,528,000
22,636,000
Tax Rate
33.12%
39.93%
NOPAT
45,496,000
34,052,000
Net income
51,006,000
0.72%
50,641,000
12.74%
Dividends
(15,588,000)
(12,712,000)
Dividend yield
1.61%
0.42%
Proceeds from repurchase of equity
(29,379,000)
(17,208,000)
BB yield
3.04%
0.57%
Debt
Debt current
57,985,000
54,743,000
Long-term debt
50,187,000
33,489,000
Deferred revenue
6,332,000
Other long-term liabilities
43,231,000
3,017,000
Net debt
(334,214,000)
(313,432,000)
Cash flow
Cash from operating activities
70,702,000
86,513,000
CAPEX
(46,233,000)
(30,285,000)
Cash from investing activities
(43,906,000)
(19,024,000)
Cash from financing activities
(39,541,000)
(44,531,000)
FCF
5,273,000
12,507,000
Balance
Cash
255,257,000
241,185,000
Long term investments
187,129,000
160,479,000
Excess cash
417,232,050
377,510,450
Stockholders' equity
607,419,000
1,060,854,000
Invested Capital
328,471,950
254,471,550
ROIC
15.61%
10.56%
ROCE
9.12%
8.63%
EV
Common stock shares outstanding
310,032
312,428
Price
3,119.00
-67.61%
9,630.00
47.70%
Market cap
966,989,808
-67.86%
3,008,681,640
44.01%
EV
689,436,808
3,217,091,640
EBITDA
95,865,000
82,021,000
EV/EBITDA
7.19
39.22
Interest
660,000
666,000
Interest/NOPBT
0.97%
1.17%